A breakthrough in a lab doesn't save a child's life. The clinician who has the knowledge and tools to implement it does! Read to learn more about PentaTr@ining has been bridging paediatric infectious disease research & real-world practice. #PentaTraining #PentaAnnualReport2025

🔴 WEBINAR ALERT! 23 Jul, 15:00-16:00 CEST Join NeoNET Africa & NeoIPC: “From detection to prevention: surveillance and IPC in neonatal sepsis”. Including a presentation of the free online #NeoIPC #Surveillance Toolkit for neonatal units. ✍ Learn more and register: neoipc.org/join-the-neo...

#NeoSep1 has officially expanded to Pakistan! 🇵🇰 We are proud to be a partner in this innovative clinical trial, improving antibiotic treatment options for newborns with sepsis. @gardp.bsky.social @innovative-ctu.bsky.social @citystgeorges.bsky.social

Penta stands with the people of Venezuela, including our Network members, PentaTr@ining delegates, partners and collaborators, as well as all healthcare professionals working tirelessly to support affected communities and sustain essential health services for mothers and children.

Interested in joining a project aiming at improving the life of children living with #HIV? The SUPPORT project has one post-doctoral position on biostatistics currently open at Makerere University Uganda🇺🇬! More details👇 euraxess.ec.europa.eu/jobs/446832 More about SUPPORT 👉 www.supportproject.eu

🎉 𝗢𝘂𝗿 𝟮𝟬𝟮𝟱 𝗔𝗻𝗻𝘂𝗮𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗶𝘀 𝗵𝗲𝗿𝗲! Thanks to our members and collaborators, last year we expanded our research, strengthened the Network and strengthened scientific partnerships. 2025 brought us closer to improving health outcomes for children & pregnant people worldwide. 📖: lnkd.in/dCajFJra

🌍 NeoSep1 is expanding to Asia! This landmark clinical trial, already running in South Africa, Kenya & Ghana, is now enrolling in India, working to find affordable treatments for drug-resistant neonatal sepsis.

New findings from a PediCAP analysis found no difference in gut microbiota effects between oral step-down antibiotics & IV treatment. The gut also showed signs of recovery over time! A hopeful result for children with pneumonia. https://www.nature.com/articles/s44259-026-00216-5

New PIPELINE data from 1800 European parents & clinicians finds maternal #RSV vaccination ranks highest yet 1 in 5 parents haven’t heard of RSV & many mix up vaccine vs antibody options. Better education & stronger clinician–family conversations are vital to protect infants. https://bit.ly/3RLxRjX

New ODYSSEY results show that dolutegravir cut treatment failure in children with HIV (19% vs 34% at 240 weeks) and showed no new safety problems. A hopeful step for stronger, simpler care for kids worldwide! More 👉 https://academic.oup.com/ofid/article/13/5/ofag266/8669861

Happening now at #ESPID! Join us in Room Argento to learn more about PIPELINE and Be Ready projects!

We're at ESPID! Are you? Join the SLIPE-Penta session in Sala Europa & visit our stand in the Exhibition Hall!

🚨 PIs & site managers (NL 🇳🇱 IE 🇮🇪 HR 🇭🇷 NO 🇳🇴 LT 🇱🇹 LV 🇱🇻 EE 🇪🇪) The READI Project is mapping clinical trial site capabilities across Europe to improve inclusion of underrepresented populations! ⏱ 12-15 min survey 🔐 Confidential & aggregated 👉 Learn more & complete survey: ihi-readi.org/news/readi-c...

Tomorrow is #KangarooCareAwarenessDay & #NeoIPC is proud to share 2 new stories in our “NICU Journeys” series, featuring interviews with Emma & Luken's parents 💜🦘 Their experiences highlight the importance of #KangarooCare, family involvement and #IPC in the #NICU. 🎥 Watch here ➡️ lnkd.in/d-sstx5y

📢 Calling all all researchers and professionals in pharmacology! Join the 2026 #AntiviralPK workshop in Montreal, Canada (2-3 Sept) & connect with leading experts advancing the future of antiviral therapeutics. Abstract submission is open until 12 June! academicmedicaleducation.com/programs/27t...

Why are mortality rates of children living with #HIV so high? In her work in the SUPPORT project, Nsofwa Sukwa is exploring the link between #CMV viral loads and mortality rates in these children. Check out her insights in her latest blog here bit.ly/4nk1O6t

Did you know that RSV infection is dangerous for children under 5 with HIV? For these children, RSV can turn into a life-threatening condition. Read this blog by SUPPORT fellow Cheelo Mwiinga with pointers for families & caregivers of children living with HIV. supportproject.eu/understandin...

Every year, newborn sepsis claims thousands of lives. #NeoSep1 is changing that, testing safer, more effective antibiotic combinations for newborns. Now underway in South Africa, Kenya and Ghana (soon Uganda), this trial is part of #SNIP-AFRICA improving care for severe newborn infections.

This #WorldHealthWorkerWeek, we honour the people who keep health systems running. 💙 Take neonatal nurses in our #NeoIPC project: supporting families, protecting tiny lives, all with precision and care. Imagine doing that without proper support. Strong health systems need strong health workers.

A step forward in paediatric HIV research! #ENABLE brings together 21 partners across Africa, Europe & the US to test whether bNAbs can improve viral control in infants. Penta leads the Ethics & Regulatory work, ensuring the trial meets the highest standards. 👉 penta-id.org/news/enable-...

Passionate about adolescent health? Working in #HIV or #SRHR? The Adol & HIV Workshop 2026 is coming to Bangkok! 📣 Call for (Research) Abstracts Deadline: 5 June Info: academicmedicaleducation.com/programs/10t... Join us in shaping the future of adolescent health! @academicmededu.bsky.social

Last week, at the #SNIP-AFRICA General Assembly in Accra 🇬🇭, we explored how can we improve management neonatal sepsis in Africa. Through research, stakeholder engagement & training activities, this project is making real strides toward better care for newborns in this setting. www.snip-africa.org

🧵1/3 The SUPPORT project that has officially recruited 100 children into the SUPPORT 1 clinical study! For hospitalised children living with HIV, the greatest risk isn't always the hospital stay, it’s the weeks after they return home.

Today is #InternationalWomen'sDay & we stand with the theme: Rights. Justice. Action. Watch to find out what defines the women of the Penta ID Network & their vital role in helping us realise our vision where the health needs of pregnant people, infants, children & adolescents are prioritised!

📌 How do #IPC practices vary across European NICUs? Join the #NeoIPC/#UENPS webinar “Neonatal Infection Prevention in Europe: Findings from the NeoIPC-UENPS Survey” 🗓️ 5 March | 13:00–14:00 CET Discover key insights drawing from 200 responses. Register 👉 www.mcascientificevents.eu/neobestpract...

@bsky.app Why do some children and pregnant women not get vaccinated? Hint: It’s not a lack of trust in science. Helen Skirrow, the recipient of the 2026 BFA Young Researcher Award, shows how sharing power with communities drives real vaccine uptake in the UK. Congratulations, Helen.

🧵1/3 On #ZeroDiscriminationDay, we are following the global lead to put People First. 🦋 At Penta, we believe that language is the foundation of dignity. This isn't about being politically correct, it’s about ensuring that a medical condition never overshadows a child’s identity.

Catch Anna Turkova & Simon Drysdale on Feb 19 (13:20-13:50) at the RSVVW’26 conference to discuss the PIPELINE-RSV trial. Learn how PIPELINE aims to use adaptive trials to improve #RSV preparedness for pregnant people and infants across Europe. More 👉 https://resvinet.org/conferences/rsvvw26/

🧵 📢 NEWS: Kenya joins @gardp.bsky.social NeoSep1 Part 2 trial on #NeonatalSepsis. The trial has started enrolling newborn babies with #sepsis at Kilifi County Hospital (Kilifi) Coast General Teaching & Referral Hospital (Mombasa) and Mbagathi Hospital (Nairobi). 🇰🇪

Today is the #InternationalDayOfWomenAndGirlsInScience and we asked the women within the Penta ID Network to share a message for girls who are interested in STEM but are hesitant to take that step. Watch for a dose of inspiration from the women leading by example.

📢 Call for Abstracts: 𝟭𝟴𝘁𝗵 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗼𝗻 #PediatricsHIV 𝟮𝟬𝟮𝟲! Submission deadline: 17 April 2026. Join fellow researchers and clinicians to advance #HIV prevention and treatment for infants, children and adolescents. 🔗 Learn more and submit your abstract: lnkd.in/d43EaECG

Big news from the PIPELINE team! We’ve officially recruited our first participant into the PIPELINE RSV-International trial. This milestone marks the start of an important chapter bringing us closer to providing better protection against RSV in infants. More 👉 bit.ly/3O3qsdP

⏰ Last chance to submit your abstract for the 3rd Conference on Innovations in Tuberculosis - highlighting TB research and innovation in African contexts, where the burden is greatest but voices are too often underrepresented. Info & submit abstract ➡️ bit.ly/4tmOp00 @academicmededu.bsky.social

The #ENABLE kick-off meeting is underway in South Africa! @globalhealthedctp3.bsky.social Penta will coordinate Ethics & Regulatory work for a trial testing 2 #bNAbs as intensification therapy alongside oral #ART in high-risk infants with #HIV 👶🏽 Excited to be part of this impactful project 🥰

Did you know that low-risk children often receive the same antibiotic treatment as high-risk patients? This is because we lack clear data on when to safely stop care PediSEP-1 aims to change that and provide the missing data, inform policy change and protect children from #AMR!

PIPELINE RSV International has officially opened its first site! Can we better protect babies and pregnant people from #RSV? PIPELINE RSV hopes to answer this. Swipe to learn more! Read the full announcement here 👉 bit.ly/45mhtdH

📈 New NeoSep1 results! Part 1 shows that fosfomycin and flomoxef are safe and well-tolerated in babies with sepsis. Part 2, designed by our experts, compares antibiotic combinations for treating neonatal sepsis. @pentafoundation.bsky.social @gardp.bsky.social Read more about it 👇

📣 Healthcare professionals: level up your expertise in #HIV & congenital infections 🇮🇹! 🎓 PentaTr@ining course (hybrid): online modules + expert webinars + in-person workshop in Padova, Italy 🗓 Online Apr–Jul 2026 | Residential Sept 2026 🔗 Register now 👉 penta-id.org/hiv-other-co...

Good news for newborn health 👶 New findings from GARDP's #NeoSep1 trial show that off-patent antibiotics, fosfomycin & flomoxef, are safe in newborns with sepsis, supporting affordable treatment options where #AMR burden is highest 🔗 bit.ly/45oK3v1 @pentafoundation.bsky.social @mrcctu.bsky.social

Every year, sepsis claims hundreds of thousands of newborn lives, but new evidence offers hope. 👶 #NeoSep1 Part 1 shows off-patent antibiotics fosfomycin and flomoxef are safe and well tolerated in newborns with suspected #sepsis, including high-risk preterm infants. 💜 👇

On #WorldAIDSDay2025, we recognise the extraordinary efforts of the people who turn evidence into impact, researchers, clinicians and community leaders across the globe. ⬇️

Old drugs, new hope. Instead of waiting decades for new antibiotics, #NeoSep1 is rethinking the ones we already have to treat newborn sepsis more safely and effectively. 🩷 In Africa, the trial is a key pillar of #SNIPAFRICA, funded by EDCTP3 and led by Penta. 🔗 snip-africa.org 📰 Guardian feature 👇

One tablet could change everything. The UNIVERSAL 1 trial is confirming the right dose for a single, dispersible DTG/FTC/TAF pill for children with #HIV, a formulation prioritised by GAP-f. Watch for more #BetterMeds4Kids #WorldChildrensDay #PaediatricHIV #EDCTP

Strengthening paediatric #HIV care in Mozambique: #THRIVE and the Ministry of Health hosted a workshop to improve care for children with advanced HIV disease🌍 @pentafoundation.bsky.social @unitaid.bsky.social 🔗 thriveinfo.org/post/strengthening-paediatric-hiv-care-thrive-ahd-training-in-mozambique

On #WorldPneumoniaDay, we share hope for the children battling severe pneumonia. The PediCAP-A trial showed that it's safe to switch children from IV to oral antibiotics sooner! ✅ Children go home sooner ✅ No more unnecessary IVs & long stays #PediCAP #ChildHealth #Pneumonia #GlobalHealth

Incredible nominations are already coming in for #BFA2025 & we can’t wait to celebrate more champions. Our past Penta BFA winners prove that local heroes can change global health. Entries close 15 November. Nominate your hero today! www.penta-id.org/bfa

📢 3 weeks to go until the Long COVID Conference 2025! Join us in Boston or online for powerful insights from keynote speakers & expert panelists. 🔗 Final call to register: amededu.co/47cQW3M Let’s shape the future of Long COVID care together. #LongCOVIDIntl @academicmededu.bsky.social

Both premature & term newborns in European NICUs are at risk of carrying antibiotic-resistance genes, a key finding from the #NeoIPC feasibility study presented at #jENS2025. The presenter Chiara Minotti earned 1st prize in the Early Career Investigator session! 👏 View presentation: lnkd.in/dTHrFBnn

🌍 Nominate a grassroots health hero for the 2025 Penta Brighter Future Award. 🏆 €5,000 • ✈️ Italy 2026 • 🤝 Global stage 🗓️ Deadline: 15 Nov → penta-id.org/bfa #BrighterFutureAward #GlobalHealth

My name is Jennifer Furin, a Brighter Future Award winner from the United States. There’s no better time to nominate a health hero in your community for this global award. Nominations close 31 October. Nominate now: penta-id.org/bfa #BrighterFutureAward